Utah Retirement Systems’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Utah Retirement Systems’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,300	Closed	-$203K	–	1018
2018 Q1	$203K	Buy	+3,300	New	+$199K	﹤0.01%	971
2017 Q3	–	Sell	-3,300	Closed	-$400K	–	984
2017 Q2	$400K	Buy	3,300 +200	+6%	+$23.2K	0.01%	939
2017 Q1	$350K	Hold	3,100	–	–	0.01%	931
2016 Q4	$337K	Hold	3,100	–	–	0.01%	938
2016 Q3	$510K	Hold	3,100	–	–	0.01%	871
2016 Q2	$442K	Buy	3,100 +200	+7%	+$29.2K	0.01%	902
2016 Q1	$372K	Hold	2,900	–	–	0.01%	905
2015 Q4	$434K	Hold	2,900	–	–	0.01%	889
2015 Q3	$481K	Hold	2,900	–	–	0.01%	873
2015 Q2	$700K	Buy	2,900 +400	+16%	+$107K	0.02%	801
2015 Q1	$705K	Buy	2,500 +300	+14%	+$65K	0.02%	776
2014 Q4	$343K	Hold	2,200	–	–	0.01%	967
2014 Q3	$521K	Sell	2,200 -100	-4%	-$25.5K	0.01%	871
2014 Q2	$544K	Buy	+2,300	New	+$606K	0.02%	876

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Utah Retirement Systems's ICPT Position: Q2 2018 in Review

Utah Retirement Systems sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2018, closing a stake of 3,300 shares — an estimated $203K sold.

Utah Retirement Systems first reported a position in ICPT in Q2 2014 and held it in 14 quarters. The position peaked at $705K in Q1 2015. 163 funds tracked by Wall St. Rank hold ICPT as of Q2 2018.

Utah Retirement Systems reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Utah Retirement Systems sold 3,300 Intercept Pharmaceuticals, Inc. shares in Q2 2018, an estimated $203K.
Utah Retirement Systems first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 14 quarters.
Utah Retirement Systems's Intercept Pharmaceuticals, Inc. position peaked at $705K in Q1 2015.
163 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2018.

Based on Utah Retirement Systems's 13F filing for Q2 2018, filed 10 Aug 2018.